Torrent Pharmaceuticals successfully raised Rs. 12,500 crore through various debentures in January 2026 to finance its acquisition of a controlling stake in JB Chemicals & Pharmaceuticals. 

This acquisition is expected to propel Torrent Pharma from the 7th to the 5th largest player in the Indian domestic pharmaceutical market.

The capital was raised via multiple-tenure non-convertible debentures (NCDs) and commercial papers.

1-Year: Rs. 1,500 crore (Commercial Paper)
2-Year: Rs. 2,000 crore at 7.45% yield
3-Year: Rs. 2,500 crore at 7.60% yield
4-Year: Rs. 3,000 crore at 7.70% yield
5-Year: Rs. 3,500 crore at 7.80% yield

Funds were secured from mutual funds, insurance companies, and pension funds